Zobrazeno 1 - 10
of 255
pro vyhledávání: '"Izzo, B"'
Autor:
White HE, Salmon M, Albano F, Andersen CSA, Balabanov S, Balatzenko G, Barbany G, Cayuela JM, Cerveira N, Cochaux P, Colomer D, Coriu D, Diamond J, Dietz C, Dulucq S, Engvall M, Franke GN, Gineikiene-Valentine E, Gniot M, Gómez-Casares MT, Gottardi E, Hayden C, Hayette S, Hedblom A, Ilea A, Izzo B, Jiménez-Velasco A, Jurcek T, Kairisto V, Langabeer SE, Lion T, Meggyesi N, Mešanović S, Mihok L, Mitterbauer-Hohendanner G, Moeckel S, Naumann N, Nibourel O, Oppliger Leibundgut E, Panayiotidis P, Podgornik H, Pott C, Rapado I, Rose SJ, Schäfer V, Touloumenidou T, Veigaard C, Venniker-Punt B, Venturi C, Vigneri P, Vorkinn I, Wilkinson E, Zadro R, Zawada M, Zizkova H, Müller MC, Saussele S, Ernst T, Machova Polakova K, Hochhaus A, Cross NCPa 62, Andreas Hochhaus 52, Nicholas C P Cross
Publikováno v:
White, H E, Salmon, M, Albano, F, Andersen, C S A, Balabanov, S, Balatzenko, G, Barbany, G, Cayuela, J M, Cerveira, N, Cochaux, P, Colomer, D, Coriu, D, Diamond, J, Dietz, C, Dulucq, S, Engvall, M, Franke, G N, Gineikiene-Valentine, E, Gniot, M, Gómez-Casares, M T, Gottardi, E, Hayden, C, Hayette, S, Hedblom, A, Ilea, A, Izzo, B, Jiménez-Velasco, A, Jurcek, T, Kairisto, V, Langabeer, S E, Lion, T, Meggyesi, N, Mešanović, S, Mihok, L, Mitterbauer-Hohendanner, G, Moeckel, S, Naumann, N, Nibourel, O, Oppliger Leibundgut, E, Panayiotidis, P, Podgornik, H, Pott, C, Rapado, I, Rose, S J, Schäfer, V, Touloumenidou, T, Veigaard, C, Venniker-Punt, B, Venturi, C, Vigneri, P, Vorkinn, I, Wilkinson, E, Zadro, R, Zawada, M, Zizkova, H, Müller, M C, Saussele, S, Ernst, T, Machova Polakova, K, Hochhaus, A & Cross, N C P 2022, ' Standardization of molecular monitoring of CML : results and recommendations from the European treatment and outcome study ', Leukemia, vol. 36, no. 7, pp. 1834-1842 . https://doi.org/10.1038/s41375-022-01607-z
White, Helen E; Salmon, Matthew; Albano, Francesco; Andersen, Christina Søs Auður; Balabanov, Stefan; Balatzenko, Gueorgui; Barbany, Gisela; Cayuela, Jean-Michel; Cerveira, Nuno; Cochaux, Pascale; Colomer, Dolors; Coriu, Daniel; Diamond, Joana; Dietz, Christian; Dulucq, Stéphanie; Engvall, Marie; Franke, Georg N; Gineikiene-Valentine, Egle; Gniot, Michal; Gómez-Casares, María Teresa; ... (2022). Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia, 36(7), pp. 1834-1842. Springer Nature 10.1038/s41375-022-01607-z
White, Helen E; Salmon, Matthew; Albano, Francesco; Andersen, Christina Søs Auður; Balabanov, Stefan; Balatzenko, Gueorgui; Barbany, Gisela; Cayuela, Jean-Michel; Cerveira, Nuno; Cochaux, Pascale; Colomer, Dolors; Coriu, Daniel; Diamond, Joana; Dietz, Christian; Dulucq, Stéphanie; Engvall, Marie; Franke, Georg N; Gineikiene-Valentine, Egle; Gniot, Michal; Gómez-Casares, María Teresa; ... (2022). Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study. Leukemia, 36(7), pp. 1834-1842. Springer Nature 10.1038/s41375-022-01607-z
Standardized monitoring of BCR::ABL1 mRNA levels is essential for the management of chronic myeloid leukemia (CML) patients. From 2016 to 2021 the European Treatment and Outcome Study for CML (EUTOS) explored the use of secondary, lyophilized cell-ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9502926c1573fe2a3427de12f0968bf4
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-486010
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-486010
Autor:
Voso, M. T., Cucci, R., Messina, M., Santoro, A., Divona, M., Albano, F., Ottaviani, E., Roberta Bertorelle, Guerrasio, A., Gottardi, E., Izzo, B., Tarantini, G., Scardocci, A., Siragusa, S., Forghieri, F., Cairoli, R., Cambo, B., Vallisa, D., Venditti, A., Ferrara, F., Mannina, D., Cilloni, D., La Sala, E., Piciocchi, A., Falini, B., Pane, F., Saglio, G., Vignetti, M., Amadori, S.
Publikováno v:
Publons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::22aebec5099f778a56bb5d6aa6d5ca7e
https://hdl.handle.net/10281/409337
https://hdl.handle.net/10281/409337
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daraio, F, Giugliano, E, Fava, C, Lorenzatti, R, Varotto, M, Barberio, D, Bernardi, S, Izzo, B, Errichiello, S, Bochicchio, Mt, Venturi, C, Albano, F, Saglio, G, Pane, F, Martinelli, G, Specchia, G, Russo, D, Gottardi, Em
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::307637bf3d29caf50ef7834ec231d74a
http://hdl.handle.net/11585/627596
http://hdl.handle.net/11585/627596
Autor:
Izzo B., Accetta R., Caruso S., De Angelis B., Del Prete C., Errichiello S., Galdiero A., Casadei G. M., Musella F., Quintarelli C., Visconti R., Pane F.
The pathognomonic genetic alteration in CML is the formation of the BCR-ABL fusion gene, which produces a constitutively active tyrosine kinase that drives leukemic transformation. Targeted tyrosine kinase inhibitor treatment is the cornerstone of mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::ff89c8d689771aed173a9b15a916b4a2
http://hdl.handle.net/11588/813497
http://hdl.handle.net/11588/813497
Autor:
Iacobucci, I, Saglio, Giuseppe, Rosti, G, Testoni, N, Pane, F, Amabile, M, Poerio, A, Soverini, S, Bassi, S, Cilloni, Daniela, Bassan, R, Breccia, M, Lauria, F, Izzo, B, Merante, S, Frassoni, F, Paolini, S, Montefusco, E, Baccarani, M, Martinelli, G, Gimema, Working, PARTY ON CHRONIC MYELOID LEUKEMIA
Publikováno v:
Clinical cancer research
12 (2006): 3037–3042. doi:10.1158/1078-0432.CCR-05-2574
info:cnr-pdr/source/autori:Iacobucci I, Saglio G, Rosti, G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Marente S, Frassoni F, Paolini S, Montefusco E, Baccarini M, MArtinelli G, Ginema Working party/titolo:Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients/doi:10.1158%2F1078-0432.CCR-05-2574/rivista:Clinical cancer research (Print)/anno:2006/pagina_da:3037/pagina_a:3042/intervallo_pagine:3037–3042/volume:12
12 (2006): 3037–3042. doi:10.1158/1078-0432.CCR-05-2574
info:cnr-pdr/source/autori:Iacobucci I, Saglio G, Rosti, G, Testoni N, Pane F, Amabile M, Poerio A, Soverini S, Bassi S, Cilloni D, Bassan R, Breccia M, Lauria F, Izzo B, Marente S, Frassoni F, Paolini S, Montefusco E, Baccarini M, MArtinelli G, Ginema Working party/titolo:Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients/doi:10.1158%2F1078-0432.CCR-05-2574/rivista:Clinical cancer research (Print)/anno:2006/pagina_da:3037/pagina_a:3042/intervallo_pagine:3037–3042/volume:12
Purpose: Most patients with chronic-phase chronic myeloid leukemia (CML) who receive imatinib achieve a complete cytogenetic remission (CCgR) and low levels of BCR-ABL transcripts. CCgR is durable in the majority of patients but relapse occurs in a s
Molecular monitoring of chronic myeloid leukemia patients using robust BCR-ABL1 tests standardized to the International Scale (IS) is key to proper disease management, especially when treatment cessation is considered. Most laboratories currently use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::da51391840222a92c7313896af1290d4
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085790
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3085790
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.